Mirae Asset Global Investments Co., Ltd. Biomea Fusion, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $54.3 Billion
- Q1 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 15,513 shares of BMEA stock, worth $65,619. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,513
Previous 13,801
12.4%
Holding current value
$65,619
Previous $200,000
15.5%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding BMEA
# of Institutions
120Shares Held
25.7MCall Options Held
2.56MPut Options Held
879K-
State Street Corp Boston, MA4.49MShares$19 Million0.0% of portfolio
-
Cormorant Asset Management, LP Boston, MA3.57MShares$15.1 Million3.07% of portfolio
-
Laurion Capital Management LP New York, NY2.72MShares$11.5 Million0.36% of portfolio
-
Baker Bros. Advisors LP New York, NY2.11MShares$8.92 Million0.4% of portfolio
-
Black Rock Inc. New York, NY1.97MShares$8.35 Million0.0% of portfolio
About Biomea Fusion, Inc.
- Ticker BMEA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,290,600
- Market Cap $124M
- Description
- Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...